Life Science Leader Chief Editor Blog Header image Life Science Leader Chief Editor Blog Header image

How The Biopharmaceutical Industry Provides A Sparkle Of Hope
How The Biopharmaceutical Industry Provides A Sparkle Of Hope Author Steven Covey’s famous phrase, “To Live, To Love, To Learn, To Leave a Legacy” is what popped into my head while attending the Community of Hope’s Annual Dinner Auction as the invited guest of pharmaceutical industry icon, Fred Hassan. Twenty years ago Hassan founded this annual charity event that brings together two communities (i.e., social services and the biopharmaceutical industry) to do good in their own...  Continue Reading...
Will Cuba Be The World’s Next Leading Biotech Hub?
Will Cuba Be The World’s Next Leading Biotech Hub? Life Science Leader magazine was recently invited to attend The Economist’s War On Cancer healthcare forum in Boston, Sept. 28, 2016. Though all of the day’s sessions were intriguing, the one that got me up out of my chair to track down a speaker before his exit occurred at 4 p.m. Entitled, “Going Global – Examples Of Cancer Advances From Around The World,” the first person to speak was Kelvin Lee, M.D., immunology...  Continue Reading...
What I Found Enlightening About ISPE’s Annual Meeting
What I Found Enlightening About ISPE’s Annual Meeting Have you ever attended a meeting and gotten the sense of being enlightened during someone’s presentation? I recently had such an experience at the International Society for Pharmaceutical Engineering (ISPE) annual meeting and expo in Atlanta, GA. But it was neither where I expected it, nor whom I expected it from (e.g.,, keynote speakers). Don’t get me wrong, Joseph Jimenez, Dr. Stephan Grupp, M.D., Ph.D., Nicole Pierson, and Fleming ...  Continue Reading...
Beyond IPOs: Alternative Funding Options For Biotech Startups
Beyond IPOs: Alternative Funding Options For Biotech Startups “While it is great when Morgan Stanley, JP Morgan, and Goldman are fighting to take your company public, sometimes, given the investment environment, you have to play in a ‘less elegant’ part of the finance swimming pool (e.g., Form 10s and reverse mergers).” This statement by Aftab Kherani, M.D., a partner at Aisling Capital, was made in response to the question, “What are some of the more innovative ways companies ...  Continue Reading...
Can A Better Patient Experience Lead To A Better Patient Outcome?
Can A Better Patient Experience Lead To A Better Patient Outcome? My colleague, Ed Miseta, chief editor of Clinical Leader, recently asked, “Can Better Patient Experiences Lead To Better Medicines?” via an article he developed from an interview with Thomas Goetz, cofounder of Iodine, a digital health company. According to Miseta, Goetz is attempting to turn patient experiences into better medicines and is combining data and design to help patients locate the best treatments based on preferences,...  Continue Reading...
Rare Situation Results In Free Insights From GSK’s Global Vaccine President
Rare Situation Results In Free Insights From GSK’s Global Vaccine President When conducting interviews my natural curiosity can result in a surplus of interesting content that often doesn’t fit with the overall theme of the final published article. When situations like these happen, I often proactively create articles for an online section called — From The Cutting Room Floor. One of my favorite examples of a cutting room floor article being able to provide valuable insight came from an interview with George ...  Continue Reading...
Will Cupping Be The Next Big Health Fad?
Will Cupping Be The Next Big Health Fad? As I sat down to write this blog, I was struck by the idea of why certain things become popular or gain legitimacy. Malcolm Gladwell describes the magic moment when an idea, trend, or social behavior crosses a threshold and begins to spread like wildfire in his book, The Tipping Point: How Little Things Can Make a Big Difference. Still, it seems rare to witness such an event actually taking place and even more difficult to predict these...  Continue Reading...
A Commentary On Biopharma’s Current Boston Fixation
A Commentary On Biopharma’s Current Boston Fixation Merck recently announced its plans to lay off R&D workers at three East Coast sites; a move that will supposedly affect less than 10 percent of discovery, preclinical, and early development employees in Kenilworth and Rahway, N.J., and North Wales, PA.  Continue Reading...
Is BIO’s Annual Meeting Too Big?
Is BIO’s Annual Meeting Too Big? As a past BIO educational planning committee co-chair, I am well aware of the amount of effort that goes into the successful planning one of our industry’s biggest gatherings — BIO International’s Annual Convention. Typically drawing more than 15,000 attendees from nearly every U.S. state and over 65 countries, this year’s event took place June 6 – 9 at the Moscone Center in San Francisco. And while I have always...  Continue Reading...
Who Will Move Biopharma Beyond The Cutting Edge At BIO 2016?
Who Will Move Biopharma Beyond The Cutting Edge At BIO 2016? When you think of companies that revolutionized the way business is done, it is important to consider the attributes of their founders. Often they had gained life experience from working in businesses best be described as tangential to those they eventually disrupted. As a result, these “outsiders” not only brought a different perspective toward tackling problems in these industries, their wisdom to do things differently than in the...  Continue Reading...